You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Leukemia, Promyelocytic, Acute

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

RWE of 1st Line Treatment With ATO/ATRA for Adult APL

Recruiting
  • Promyelocytic Leukemia, Adult Acute
  • Evaluation of first line treatment with ATO/ATRA outcome
  • Caba, Argentina
  • +1 more
Nov 9, 2021

Acute Promyelocytic Leukemia Trial in United States (SY-2101, Arsenic Trioxide)

Recruiting
  • Acute Promyelocytic Leukemia
  • Birmingham, Alabama
  • +4 more
Jul 12, 2022

Acute Promyelocytic Leukemia Trial in Xi'an (Realgar-Indigo naturalis formula, all-trans retinoic acid, Arsenic trioxide)

Recruiting
  • Acute Promyelocytic Leukemia
  • Realgar-Indigo naturalis formula
  • +3 more
  • Xi'an, Shaanxi, China
    First Affiliated Hospital of Xi'an Jiaotong University
Aug 31, 2021

Promyelocytic Leukemia Trial in Monterrey (Arsenic trioxide, all-trans retinoic acid)

Recruiting
  • Promyelocytic Leukemia
  • Arsenic trioxide
  • all-trans retinoic acid
  • Monterrey, Nuevo Leon, Mexico
    Hopsital Universitario Dr. Jose E. Gonzalez, Centro Universitari
Aug 9, 2022

Leukemia Trial in Tianjin (DNR:, Ara-c)

Completed
Has Results
  • Leukemia
  • Tianjin, Tianjin, China
  • +1 more
Aug 8, 2021

Acute Promyelocytic Leukemia Trial in Hong Kong (Oral arsenic Trioxide, ATRA and ascorbic acid)

Recruiting
  • Acute Promyelocytic Leukemia
  • Oral arsenic Trioxide, ATRA and ascorbic acid
  • Hong Kong, N/A = Not Applicable, Hong Kong
    Department of Medicine, the University of Hong Kong, Queen Mary
Nov 3, 2020

Acute Promyelocytic Leukemia Trial in Canada, United States (Tretinoin and Arsenic Trioxide)

Completed
Has Results
  • Acute Promyelocytic Leukemia
  • Tretinoin and Arsenic Trioxide
  • Los Angeles, California
  • +11 more
Nov 2, 2021

Results From a Mexican Acute Promyelocytic Leukemia.

Completed
  • Promyelocytic Leukemia, Acute
  • Diagnosis
  • +2 more
  • Mexico, Mexico City, Mexico
    Nidia Zapata
Sep 18, 2020

Acute Promyelocytic Leukemia Trial in Hong Kong (Oral Arsenic Trioxide Formulation)

Recruiting
  • Acute Promyelocytic Leukemia
  • Oral Arsenic Trioxide Formulation
  • Hong Kong, Hong Kong
    The University of Hong Kong
Dec 29, 2020

Acute Promyelocytic Leukemia Trial in Bari, Pavia, Roma (all-trans retinoic acid (ATRA))

Recruiting
  • Acute Promyelocytic Leukemia
  • all-trans retinoic acid (ATRA)
  • Bari, Italy
  • +2 more
Oct 12, 2020

Acute Promyelocytic Leukemia Trial in Worldwide (Mylotarg, Arsenic Trioxide, All-trans retinoic acid)

Recruiting
  • Acute Promyelocytic Leukemia
  • Brussels, Belgium
  • +30 more
Aug 9, 2022

Safety and Efficacy Trial in Suzhou (Ruxolitinib)

Unknown status
  • Safety and Efficacy
  • Suzhou, Jiangsu, China
    First Affiliated Hospital, Soochow University
Jun 22, 2020

AML According to WHO 2016 Classification (Except Acute Promyelocytic Leukemia) AND (Refractory to Induction Therapy OR Relapsed

Recruiting
  • AML According to WHO 2016 Classification (Except Acute Promyelocytic Leukemia) AND (Refractory to Induction Therapy OR Relapsed After First Line Treatment)
  • MRD-triggered arm
  • Prophylactic Arm
  • Heidelberg, BW, Germany
    University Hospital Heidelberg Med5
Jan 4, 2021

Arsenic Trioxide in Newly Diagnosed, Low-to-intermediate Risk

Recruiting
  • Acute Promyelocytic Leukemia
  • Arsenic Trioxide
  • Alessandria, Italy
  • +27 more
Dec 31, 2021

Long-term QoL in Acute Promyelocytic Leukemia Treated With ATO

Active, not recruiting
  • Acute Promyelocytic Leukemia
  • QoL questionnaires
  • Ascoli Piceno, Italy
  • +15 more
Feb 3, 2021

The Acute Promyelocytic Leukaemia Asian Consortium Project

Recruiting
  • Acute Promyelocytic Leukemia
    • Hong Kong, Hong Kong
      Department of Medicine, the University of Hong Kong, Queen Mary
    Feb 3, 2020

    Acute Lymphoblastic Leukemia or Acute Promyelocytic Leukemia

    Active, not recruiting
    • Leukemia
    • +2 more
    • laboratory biomarker analysis
    • San Diego, California
    • +50 more
    Aug 16, 2021

    Acute Myeloid Leukemia With FLT3/ITD Mutation, Acute Myeloid Leukemia With Inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,

    Active, not recruiting
    Has Results
    • Acute Myeloid Leukemia With FLT3/ITD Mutation
    • +5 more
    • Biopsy
    • +7 more
    • Lewes, Delaware
    • +42 more
    Mar 15, 2022

    Acute Promyelocytic Leukaemia Trial (Compound Realgar-Indigo Naturalis Formula Plus Retinoic Acid)

    Not yet recruiting
    • Acute Promyelocytic Leukaemia
    • Compound Realgar-Indigo Naturalis Formula Plus Retinoic Acid
    • (no location specified)
    Nov 26, 2019

    Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in

    Active, not recruiting
    • Accelerated Phase Chronic Myelogenous Leukemia
    • +125 more
    • tetanus-CMV fusion peptide vaccine
    • laboratory biomarker analysis
    • Duarte, California
      City of Hope Medical Center
    Feb 28, 2022

    Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22);

    Completed
    Has Results
    • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
    • +10 more
    • Erlotinib Hydrochloride
    • Laboratory Biomarker Analysis
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 18, 2019

    Pregnancy in Acute Promielocitic Leukaemia Patients Treated With

    Recruiting
    • Acute Promyelocytic Leukemia
    • Pregnancy
      • Alessandria, Italy
      • +36 more
      Dec 31, 2021

      Childhood Acute Promyelocytic Leukemia (M3), Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies Trial in

      Active, not recruiting
      Has Results
      • Childhood Acute Promyelocytic Leukemia (M3)
      • Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies
      • arsenic trioxide
      • +7 more
      • Birmingham, Alabama
      • +110 more
      Mar 23, 2022

      Leukemia Trial in Austria, Germany, Italy (arsenic trioxide, idarubicin, mercaptopurine)

      Active, not recruiting
      • Leukemia
      • arsenic trioxide
      • +5 more
      • Innsbruck, Austria
      • +109 more
      Dec 31, 2021

      Acute Promyelocytic Leukemia Trial in Shanghai (ATRA+Arsenic, ATRA+Chemo)

      Unknown status
      • Acute Promyelocytic Leukemia
      • Shanghai, China
        Department of Hematology
      Aug 15, 2019